Joseph A. Marascio, MD

Radiation Oncology
Accepting new patients
Sees patients age 18 and up
Penn Medicine | Virtua Radiation Oncology - Voorhees
Headshot of Joseph A. Marascio, MD
Penn Medicine Provider

About me

My education and training

  • Medical School: Geisinger Commonwealth School of Medicine
  • Residency: Penn State Milton S. Hershey Medical Center
  • Residency: Augusta University
  • Residency: Thomas Jefferson University Hospital

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Marascio is a Penn Medicine physician. In New Jersey, providers are affiliated with Penn Medicine through Clinical Health Care Associates of New Jersey or Princeton Healthcare Affiliated Physicians, PC.

Qualifications and experience

Treatments and Conditions

Research

Publications

David C Qian, Joseph A Marascio, Rachel Tobillo, Joshua W Lorenz, Neal S McCall, Stewart G Neill, Kimberly B Hoang, Jeffrey Olson, Bree R Eaton, Hui-Kuo G Shu, Jim Zhong Development and validation of a prognostic gene expression signature for lower-grade glioma following surgery and adjuvant radiotherapy , Radiotherapy and Oncology, 175: 2022,93-100


Joseph Marascio, Daniel E Spratt, Jingbin Zhang, Edouard J Trabulsi, Tiffany Le, Worlanyo Sosu Sedzorme, Whitney H Beeler, Elai Davicioni, Bashar Dabbas, Daniel W Lin, John L Gore, Matthew Bloom, Mark Mann, J Ryan Mark, Anne Calvaresi, James L Godwin, Peter McCue, Mark D Hurwitz, W Kevin Kelly, Costas D Lallas, Karen E Knudsen, Leonard G Gomella, Adam P Dicker, Robert B Den Prospective Study to define the clinical utility and benefit of decipher testing in men following prostatectomy , Prostate Cancer and Prostatic Diseases: 2020,295-302